DK2717941T3 - Behandling af cancer - Google Patents

Behandling af cancer Download PDF

Info

Publication number
DK2717941T3
DK2717941T3 DK12727916.4T DK12727916T DK2717941T3 DK 2717941 T3 DK2717941 T3 DK 2717941T3 DK 12727916 T DK12727916 T DK 12727916T DK 2717941 T3 DK2717941 T3 DK 2717941T3
Authority
DK
Denmark
Prior art keywords
cancer
treatment
Prior art date
Application number
DK12727916.4T
Other languages
English (en)
Inventor
Graham Cotton
Ola Winqvist
Original Assignee
Tla Targeted Immunotherapies Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tla Targeted Immunotherapies Ab filed Critical Tla Targeted Immunotherapies Ab
Application granted granted Critical
Publication of DK2717941T3 publication Critical patent/DK2717941T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/521Chemokines
DK12727916.4T 2011-06-13 2012-06-13 Behandling af cancer DK2717941T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161496242P 2011-06-13 2011-06-13
PCT/GB2012/051351 WO2012172341A2 (en) 2011-06-13 2012-06-13 Treating cancer

Publications (1)

Publication Number Publication Date
DK2717941T3 true DK2717941T3 (da) 2020-07-13

Family

ID=46317437

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12727916.4T DK2717941T3 (da) 2011-06-13 2012-06-13 Behandling af cancer

Country Status (5)

Country Link
EP (2) EP2717941B1 (da)
CN (1) CN103857421B (da)
DK (1) DK2717941T3 (da)
ES (1) ES2800316T3 (da)
WO (1) WO2012172341A2 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0619820A2 (pt) 2005-12-13 2011-10-18 Exthera Ab método de remoção extracorpórea de um micróbio patogênico, uma célula inflamatória ou uma proteìna inflamatória do sangue
WO2008155683A1 (en) 2007-06-18 2008-12-24 Firmenich Sa Malodor counteracting compositions and method for their use
US8758286B2 (en) 2009-12-01 2014-06-24 Exthera Medical Corporation Method for removing cytokines from blood with surface immobilized polysaccharides
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
DK2861273T3 (da) 2012-06-13 2017-11-27 Exthera Medical Corp Anvendelse af heparin og kulhydrater til behandling af cancer.
EP3013445B1 (en) 2013-06-24 2019-11-06 ExThera Medical Corporation Blood filtration system containing mannose coated substrate
JP6806563B2 (ja) 2013-11-08 2021-01-06 エクステラ・メディカル・コーポレーション 吸着媒体を使用する感染症の診断法
US10226566B2 (en) 2014-04-23 2019-03-12 Genadyne Biotechnologies, Inc. System and process for removing bodily fluids from a body opening
BR112016024569B1 (pt) 2014-04-24 2023-01-03 Exthera Medical Corporation Método ex vivo para remover bactérias de uma amostra retirada de um indivíduo que é suspeito de estar infectado com a mesma
AU2015321601B2 (en) 2014-09-22 2020-04-23 Exthera Medical Corporation Wearable hemoperfusion device
EP3422943A4 (en) 2016-03-02 2019-10-16 ExThera Medical Corporation METHOD OF TREATING DRUG ENTRIES
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
ITUA20162865A1 (it) * 2016-04-26 2017-10-26 Istituto Scient Romagnolo Per Lo Studio E La Cura Dei Tumori I R S T S R L Dispositivo e metodo per l’eliminazione di entità biologiche e/o chimiche indesiderate da fluidi biologici
CN106191048B (zh) * 2016-09-30 2019-02-01 北京大学人民医院 定量检测ccl17基因表达的引物和探针及其应用
CN106432424B (zh) * 2016-10-18 2019-11-12 国家纳米科学中心 一种抑制肿瘤转移的多肽及其应用
JOP20190187A1 (ar) 2017-02-03 2019-08-01 Novartis Ag مترافقات عقار جسم مضاد لـ ccr7
AU2019276939A1 (en) * 2018-05-28 2021-01-21 Orion Biotechnology Switzerland Sàrl CCR5 inhibitor for use in treating cancer
BR112022014623A2 (pt) 2020-02-14 2022-09-13 Jounce Therapeutics Inc Anticorpos e proteínas de fusão que se ligam a ccr8 e usos dos mesmos
KR20230088426A (ko) 2020-10-16 2023-06-19 라노바 메디신즈 리미티드 컴파니 항-ccr8 단클론성 항체 및 그것의 용도
AU2022359841A1 (en) * 2021-10-06 2024-05-02 Virothera Ltd Novel immune regulator
WO2024088346A1 (en) * 2022-10-28 2024-05-02 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Anti-ccr8 antibodies and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3310727A1 (de) * 1983-03-24 1984-10-04 B. Braun Melsungen Ag, 3508 Melsungen Verfahren und vorrichtung zur selektiven, extrakorporalen abtrennung pathologischer und/oder toxischer blutbestandteile
AU3370000A (en) 1999-02-22 2000-09-14 Millennium Pharmaceuticals, Inc. Biotinylated-chemokine antibody complexes
US7919083B2 (en) * 2002-11-15 2011-04-05 Morehouse School Of Medicine Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms
EP1777523A1 (en) * 2005-10-19 2007-04-25 INSERM (Institut National de la Santé et de la Recherche Médicale) An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
EP2067495A4 (en) * 2006-09-29 2012-03-21 Toray Industries ADSORBENT COLUMN OF CELLS
WO2010029317A2 (en) * 2008-09-10 2010-03-18 Ibd Column Therapies International Ab Treating inflammatory conditions
GB0909906D0 (en) * 2009-06-09 2009-07-22 Affitech As Antibodies
IN2012DN01769A (da) * 2009-08-28 2015-06-05 Vlst Corp
WO2012112724A1 (en) * 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines

Also Published As

Publication number Publication date
CN103857421A (zh) 2014-06-11
EP2717941A2 (en) 2014-04-16
CN103857421B (zh) 2017-09-22
EP3693041A1 (en) 2020-08-12
WO2012172341A3 (en) 2013-03-07
ES2800316T3 (es) 2020-12-29
WO2012172341A2 (en) 2012-12-20
EP2717941B1 (en) 2020-04-01

Similar Documents

Publication Publication Date Title
DK2785349T3 (da) Kombinationsbehandling af cancer
DK2717941T3 (da) Behandling af cancer
DK2897620T3 (da) Fremgangsmåde til behandling af cancer
BR112014007603A2 (pt) métodos de tratamento do câncer
DK3354747T3 (da) Ikke-invasiv bestemmelse af tumormethylom fra plasma
DK2846809T3 (da) Behandling af myelosuppression
DK2707030T3 (da) Cancerbehandlinger
DK2968208T3 (da) Behandling af kataplexi
DK3520805T3 (da) Sammensætninger til behandling af myelofibrose
BR112013032887A2 (pt) cateter
BR112014012880A2 (pt) tratamento imunogênico do câncer
DK2854769T3 (da) Fremgangsmåder til behandling af artritis
DK3626270T3 (da) Behandling af kardiovaskulære sygdomme
DK2760886T3 (da) Immunocytokin-kombinationsterapi
BR112013033974A2 (pt) terapia de combinação
DK2733803T4 (da) Sektion af kabelbakke
FI20115876A0 (fi) Yhdistelmähoito
BR112013011659A2 (pt) métodos de tratamento do câncer
DK2906580T3 (da) Behandling af amyotrofisk lateral sklerose
IL228430A0 (en) Cancer treatment
BR112013022505A2 (pt) reconhecimento de campo de irradiação
CO6880064A2 (es) Métodos terapéuticos
DK2701707T3 (da) Fremgangsmåde til behandling af dyskinesi
DK2673363T3 (da) Behandling af angiogenesesygdomme
DK2838850T3 (da) Oprensning af titantetrachlorid